- Home
- GNK vs TRML Comparison
GNK vs TRML Comparison
Compare GNK & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNK
- TRML
- Stock Information
- Founded
- GNK 2004
- TRML 2021
- Country
- GNK United States
- TRML United States
- Employees
- GNK N/A
- TRML N/A
- Industry
- GNK Marine Transportation
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- GNK Consumer Discretionary
- TRML Health Care
- Exchange
- GNK Nasdaq
- TRML Nasdaq
- Market Cap
- GNK 707.5M
- TRML 598.9M
- IPO Year
- GNK 2005
- TRML N/A
- Fundamental
- Price
- GNK $16.87
- TRML $22.75
- Analyst Decision
- GNK Strong Buy
- TRML Strong Buy
- Analyst Count
- GNK 3
- TRML 7
- Target Price
- GNK $19.33
- TRML $50.14
- AVG Volume (30 Days)
- GNK 573.0K
- TRML 145.9K
- Earning Date
- GNK 08-06-2025
- TRML 08-13-2025
- Dividend Yield
- GNK 8.53%
- TRML N/A
- EPS Growth
- GNK 0.36
- TRML N/A
- EPS
- GNK 0.36
- TRML N/A
- Revenue
- GNK $350,742,000.00
- TRML N/A
- Revenue This Year
- GNK N/A
- TRML N/A
- Revenue Next Year
- GNK $8.77
- TRML N/A
- P/E Ratio
- GNK $48.16
- TRML N/A
- Revenue Growth
- GNK N/A
- TRML N/A
- 52 Week Low
- GNK $11.20
- TRML $11.56
- 52 Week High
- GNK $19.51
- TRML $29.79
- Technical
- Relative Strength Index (RSI)
- GNK 64.45
- TRML 67.63
- Support Level
- GNK $16.82
- TRML $22.57
- Resistance Level
- GNK $17.18
- TRML $24.56
- Average True Range (ATR)
- GNK 0.37
- TRML 1.05
- MACD
- GNK 0.01
- TRML 0.02
- Stochastic Oscillator
- GNK 92.62
- TRML 84.76
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.